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Background: The knowledge of the healing virtues of Catharanthus roseus and a host of other medicinal plants has 
been in existence since ancient times. Catharanthus roseus is traditionally used more commonly as anti-diabetic and 
anti-malaria remedy. Lack of adequate pharmacological and toxicological data of natural products to support their use 
is a major setback.  
Objective: To establish the acute toxicity effect of Catharanthus roseus crude aqueous extract on some hematological 
and biochemical parameters. 
Methodology: Catharanthus roseus aqueous extract was orally administered once to two groups of male rats at 1000 
and 5000 mg/kg body weight respectively alongside a control group which received 2ml distilled water. 
Hematological and biochemical assays were done at 48 hours and the 14th day. The data was analyzed using SPSS 17.0.   
Results: White blood cells (WBC), creatinine, urea, alanine aminotransferase and aspartate aminotransferase showed 
significant increase while mean cell volume reduced significantly at 48 hours in the high dose group. The body weight 
change was also significantly reduced.  
Discussion: The alterations of the body weight gain, various biochemical and hematological parameters reflect the 
effect of toxicity after exposure of the tested extract doses. Total proteins concentration was not altered suggesting 
that the renal and liver functions were not adversely affected. 
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1. Introduction 
Natural products remedies are believed to be safer and 
less damaging to the human body than the synthetic 
drugs (Alam et al, 2011). However, their safety has 
continually been questioned due to reported illness and 
fatality of the test animals (Park et al, 2010). Little 
pharmacological and toxicological data is available for 
most common such remedies (Fragoso et al, 2008). It is 
therefore important to determine the safety of these 
remedies in order to support their use.  
Acute toxicity is an initial screening step required in the 
toxic assessment and evaluation characteristics of all 
biological compounds (Akhila et al, 2007) and it 
establishes the median lethal dose (LD50) of a substance 
(Robinson et al, 2007). Acute toxicity is usually defined 
as the adverse changes occurring immediately or a 
short time following a single exposure to a substance 
within 24 hours (OECD, 2000). An adverse effect results 
in functional impairment and/or biochemical lesions 
and affects the performance of the whole organism 
(Rhodes, 1993). Furthermore, the information on acute 
systemic toxicity generated by the test is used in hazard 
identification and risk management in the context of 
production, handling, and use of pharmacological 
products (Leahy, 1997). Regulatory safety assessment 
for natural products relies on both the assessment of 
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cases of adverse reactions and the review of published 
toxicity information (De Smet, 1995).  
Catharanthus roseus is a renowned medicinal plant, and 
is a rich source of alkaloids, which are distributed in all 
parts of the plant (Sing et al, 1997). It has traditionally 
been used to treat diverse ailments such as eye 
inflammations, rheumatism and diabetes. Among the 
Luo community in Kenya, C. roseus (rosy periwinkle) is 
used as an antimalarial and antidiabetic remedy 
(Kokwaro, 1976). Two of the dimeric alkaloids 
vinblastine and vincristine mainly present in the aerial 
parts, have found extensive application in the treatment 
of human neoplasm. Among the monomeric alkaloids 
ajmalicine (raubacine) found in the roots has been 
confirmed to have a broad application in the treatment 
of circulatory diseases, especially in the relief of 
obstruction of normal cerebral blood flow (Aslam et al, 
2010). C. roseus exhibits high in vitro antiplasmodial 
activity, which may be due to the presence of 
compounds such as alkaloids, terpenoids flavonoids and 
sesquiterpenes that were previously isolated from the 
plant (Jaleel and Panneerselvam, 2007; Collu et al, 2001; 
Vimala , 2001; Hirose and Ashihara, 2004)  
Reported indications of C. roseus extract include 
cytotoxic effect on cell division and malfunctioning of 
the nerves which control digestion, cardiac and sexual 
functions (Lobert et al, 1997; Alexandrova et al, 2000). 
Therefore the impairment of vital organs by the crude 
extract of this plant when consumed cannot be ruled 
out. C. roseus alkaloids toxicity has previously been 
reported (Rosazza et al, 1992). This showed selective 
reversible inhibition of monoamine oxidase-B (MAO-B) 
that is important in the biotransformation of xenobiotic. 
Isolated alkaloids have also been indicated in 
neurotoxicity and bone marrow depression (Barnett et 
al, 1978). 
2. Materials and Methods 
2.1 Sample collection and authentication 
Catharanthus roseus leaves were collected from the 
flower gardens of the University of Nairobi. Kenya. 
Identification and authentication was done at the 
herbarium, School of Biological Sciences, University of 
Nairobi. A voucher specimen (ZNK/2015/01) was 
deposited in the herbarium. 
2.2 Extraction procedure 
The C. roseus leaves were cleaned and rinsed with 
distilled water and air dried at room temperature (22-
26°C) to a constant weight. The dried leaves were 
ground to a uniform powder using an electric mill. The 
powder (100 g) was soaked in 1L distilled water for 48 
hours. The mixture was filtered through cotton wool 
and then with filter paper (125 mm). The filtrate was 
frozen at -20° C for 24 hours followed by freeze drying. 
The powdered extract was weighed into air tight 
polythene bags and stored sealed in the refrigerator at 
4° C and used within five days.  
2.3 Laboratory animals 
Male Wistar albino rats (205 – 225 g) were obtained 
from the animal house of the department of 
Biochemistry, University of Nairobi and housed in the 
research room of this department. The room was well 
ventilated and maintained on light for 12 hours and 12 
hour darkness. Temperatures were maintained at 27– 
30 °C. The rats were provided with the standard rat 
pellets and clean water ad libitum.  
2.4 Acute toxicity study 
The animals were randomly assigned into three groups 
of 5 rats each and kept overnight fasting prior to extract 
administration. Group 1 served as the control and the 
rats were orally administered with 2ml distilled water. 
Two concentrations of the C. roseus aqueous extract; 
1000 and 5000 mg/kg body weight were constituted 
each in 2ml distilled water and orally administered to 
groups 2 and 3 respectively through a rat gavage. Food 
was withheld for further 3 hours.   
The rats were observed after every 30 minutes post 
extract administration for the first 2 hours and latter 
once a day up to the 14th for changes in skin and fur, 
eyes and mucus membranes, behavior pattern, tremors, 
salivation, diarrhea, sleep, coma, mortality, moribund, ill 
health or  any visible reaction to treatment. Weight 
recording was done before extract administration, at 48 
hours, day 7 and day 14 using a sensitive balance.  
2.5 Animal bleeding, hematological and 
biochemical assays   
Blood from each rat was collected at 48 hours and the 
14th day post extract administration via the tail lateral 
vein using a 2 ml hypodermic syringe and needle when 
the animal was restrained. A blood aliquot (1.3 ml) was 
put into EDTA tubes and thoroughly mixed for 
hematological analysis. The remaining 0.5 ml was put in 
plain tubes for biochemical assays.  
Hemoglobin concentration (Hb), packed cell volume 
(PCV), red blood cells (RBC), white blood cells (WBC), 
mean corpuscular hemoglobin (MCH), mean cell volume 
(MCV), mean corpuscular hemoglobin concentration 
(MCHC) and thrombocytes (THROMB) were analyzed 
using hematological analyzer (Melet Schoesing MS4, 
France) within six hours of blood harvesting. The blood 
in the plain tubes was centrifuged at 3000 revolutions 
per minute (rvm) for 10 minutes to extract serum. The 
serum was kept at -20 °C awaiting analysis.  
UV-Vis spectrophotometer (UVmini-1240, Shimadzu) 
was used for biochemical assays. Total proteins, ALAT 
and AST were assayed using ‘Human’ commercial kits 
coded EN-GPTU INF122120D for the GPT enzymes and 
SU-PROT INF 157001GB for total proteins. EMEKYN 
urea kit and EUROCHEM creatinine kits (Euromed, UK) 
were used for the assay of urea and creatinine 
respectively. The manufacturer’s protocol was followed. 
2.6 Statistical Analysis  
The data was analyzed using SPSS 17.0 and the results 
were expressed as mean ± standard deviation of the 
mean (SD). One-way analysis of variance (ANOVA) was 
employed for between and within group comparison. 95 
% level of significance (p≤0.05) was used for the 
statistical analysis. 
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2.7 Ethical Considerations 
The animal studies were in compliance with the ethical 
procedure for the care and use of laboratory animals 
approved by the Animal Care and Use Committee 
(ACUC) of the Faculty of Veterinary Medicine University 
of Nairobi. 
3.  Results 
3.1 Cage side observations:  
None the 15 rats died during the experimental time and 
therefore the median lethal dose (LD50) of the aqueous 
extract in Wistar rats was estimated to be ≤ 
5000mg/kg/body. The rats fed with 5000mg were 
found to have limited morbidity for the first 6 hours but 
latter normalized.  
No other clinical sign was observed. The general 
behavior of the rats was found to be normal throughout 
the study period.   
3.2 Weight, hematological, biochemical changes 
The two treatment groups showed very significantly 
reduced total weight gain in comparison with the non-
treated group, as shown in Table 1. 
White blood cells (WBC) had been significantly elevated 
at 48 hours for the 1000 mg/kg group and at 14th for 
the 5000mg/kg group. Mean cell volume mean (MCV) at 
48 hours was reduced significantly for the 5000mg/kg 
group but latter normalized at day 14 (Table 2). All the 
other tested hematological parameters were not 
significantly different from the control. Table 2 shows 
that the 5000mg/kg treatment group had significantly 
high ALAT, P< 0.05 at day 14. The mean AST at 48 had 
no significant difference with the control, but at day 14 
there was significant increase in the enzyme levels in 
the two treatment groups. A significant increase in the 
mean creatinine was recorded at 48 hours testing in 
5000mg/kg group while the mean urea in the same 
group was significantly high. Mean total proteins was 
not significant different from the control in all the 
testing. 
 Table 1: Weight profile of the male Wister rats in C. roseus acute toxicity testing 
 Control 1000mg 5000mg 
Initial weight 217.4±9.4 222.7±10.0 217.3±9.0 
At 48 hours 219.2±8.9 220.5±9.5 214.5±10.4 
7 days 226.9±8.7 228.2±9.5 220.8±7.2 
14 days 239.2±8,6 235±8.2 226.7±6,5 
Total gain 22±1.5 *12.3±2.9 *9.4±3.3 
% weight gain 8.5 *4.6 *3.6 
 * Significantly different from the control 
Table 2: Effect of C. roseus aqueous extract on hematological and biochemical measurements in male Wister rats after 
48 hours and at day 14 
Parameter 
Control    
48 hr. 
Control 
day 14 
1000 mg 
48 hr. 
1000 mg 
day 14 
5000 mg 
48 hr. 
5000 mg 
day 14 
WBC (10³/μl) 10.1   ± 2.7 9.1±.34 *29.0 ±12 14.1±1.4 12.6 ±.27 *15.7±1.8 
RBC (106xμl) 5.6   ±   .22 5.7± .57 5.25 ±.1 5.8±.43 6.7 ±.20 6.3±.32 
PCV (%) 35.1 ±  1.5 35.2± 3.1 35.6 ±1.5 36.3±2.0 38 ±1.2 38.2±.76 
Hb (g/dl) 14.0  ± .81 12.8± 1.5 14.4 ±.39 14.8±.83 14.7 ±.42 14.9±.46 
MCV(fl) 63.9 ±  .60 63±  1.4 66.1 ±2.7 64.1±2.4 *22.9±13 61.2±24.2 
MHC(pg) 24.0 ±   1.2 23.8±. 82 27.3 ±.59 25.7±1.4 22.1 ±.20 24.2±.92 
MCHC (g/dl) 38.5 ±  .91 38± 1.1 41.6 ±2.4 40.2±.63 38.2 ±1.2 38.7±.82 
Thromb. (10³/μl) 336.2±59.8 386± 20 208.2 ±2.4 398±60 347 ±78.6 361.6±11.4 
AST (U/L) 45.6± 15.1 45.6± 15.1 43.4±10.1 43.7±6.1  53±8.0 43.8±7.3  
ALAT(U/L) 46.4 ±2.4 46.4±2.4  42.9±4.4 38.6±8.5  *27.4±4.6 *58.1 ±4.3 
T. proteins (g/dl) 7.7± 5.2 7.7±5.2  5.9±1.6 8.0±1.1  6.2±1.1 7.9±1.0  
Creatinine(mg/d) 1.7± .36 1.7±.36  1.7±.65 1.3±.50  1.5±.64 *16.6±3.7  
Urea (mg/dl) 42.9± 3.7 42.9±3.7  *70.6±15 42.0±7.2  29±6.3 *56.1±10.0  
 * Significantly different from the control 
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4. Discussion 
C. roseus is a well-known medicinal plant and is widely 
used in the Kenya ethnomedicine (Kokwaro, 1996). The 
current study used water solvent for crude extraction 
justifying the ethnomedical practice with the traditional 
healers (Johns et al, 1990).The median lethal dose 
(LD50) estimated to be more than 5000mg/kg/body 
weight in the Wistar rats is regarded as in safe category 
of drugs (OECD, 2000). Previous studies showed that 
4000mg/kg body weight of aqueous C. roseus extract 
orally administered to mice did not cause adverse 
effects to these animals (Chattopadhyay et al, 1991). 
The altered weight gains implied narrow safety margin 
and therefore this extract should be used cautiously. It 
was suggested that the tested doses could have 
interfered with the normal metabolism consequently 
affecting the uptake of food (Chokshi, 2007; Kevin et al, 
2012) 
The WBC in 1000mg/ kg group at 48 hours recorded a 
significant increase and then normalized at day 14, 
tables 2, suggesting that the extract might have caused 
an interference in the production of lymphocytes The 
mean cell volume (MCV) is an index of the size of the 
RBC. The low MCV reported is an implication of 
pathological changes of the kidney or a micryotic 
anemia (Chernecky et al, 2001). In this study the toxic 
effect was produced only at the higher dose and at 48 
hours.  
Elevated ALT and AST at day 14 agrees with James et al, 
(2007), where these enzymes were significantly 
elevated in rabbits fed with aqueous extract of C.roseus. 
Alanine aminotransferase, a cytoplasmic enzyme, is 
found in very low concentration in the liver and is 
released into the plasma following hepatocellular 
damage. Therefore this study suggested that this extract 
could possesses hepatotoxic effect. Similar observation 
was made by Pinkerton et al (1988) who tested a 
continuous infusion of C. roseus alkaloid Vincristine and 
found a transient increase in liver enzymes. 
Elevated creatinine and urea levels, table 2, suggested a 
possible dysfunctioning of the kidneys. These two 
biochemical metabolites are critical and sensitive 
indicators of kidney function (Obidah et al, 2009). 
Earlier studies found an increment tread of these 
compounds in mice treated with of C. roseus leaves 
extract (James et al 2007).  
The total proteins content in the treatment groups did 
not show any significant difference with the control 
group, an implication that the liver and renal functions 
were not adversely impaired (Kachmar and Grant, 
1982). 
5. Conclusion 
According to the current findings, the use of C. roseus 
extract as an infusion for disease remedy may be well 
tolerated since there was no mortality or sever adverse 
effects of the test animals hence supporting the 
therapeutic use of this plant. However there is a risk of 
renal- hepato- and hematopoeitic toxicity at the tested 
doses. The study recommends the use of lower 
concentrations than 1000mg/kg in order to increase the 
safety margin. Safety measures that include monitoring 
of the vital serum enzyme and hematological 
parameters are recommended when this extract is 
being administered. Comprehensively screening for 
possible toxicity on sub-acute, sub-chronic and chronic 
levels was also recommended. The findings of this study 
provide basis for the selection of doses for use in long-
term toxicity studies. 
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